Redox regulation of hemodynamics response to diadenosine tetraphosphate an agonist of P2 receptors and renal function in diet-induced hypercholesterolemic rats

Physiol Rep. 2021 Jun;9(11):e14888. doi: 10.14814/phy2.14888.

Abstract

Hypercholesterolemia and oxidative stress may lead to disturbances in the renal microvasculature in response to vasoactive agents, including P2 receptors (P2R) agonists. We investigated the renal microvascular response to diadenosine tetraphosphate (Ap4 A), an agonist of P2R, in diet-induced hypercholesteremic rats over 28 days, supplemented in the last 10 days with tempol (2 mM) or DL-buthionine-(S,R)-sulfoximine (BSO, 20 mM) in the drinking water. Using laser Doppler flowmetry, renal blood perfusion in the cortex and medulla (CBP, MBP) was measured during the infusion of Ap4 A. This induced a biphasic response in the CBP: a phase of rapid decrease was followed by one of rapid increase extended for 30 min in both the normocholesterolemic and hypercholesterolemic rats. The phase of decreased CBP was not affected by tempol or BSO in either group. Early and extended increases in CBP were prevented by tempol in the hypercholesterolemia rats, while, in the normocholesterolemic rats, only the extended increase in CBP was affected by tempol; BSO prevented extended increase in CBP in normocholesterolemic rats. MBP response is not affected by hypercholesterolemia. The hypercholesterolemic rats were characterized by increased urinary albumin and 8-isoPGF excretion. Moreover, BSO increased the urinary excretion of nephrin in the hypercholesterolemic rats but, similar to tempol, did not affect the excretion of albumin in their urine. The results suggest the important role of redox balance in the extracellular nucleotide regulation of the renal vasculature and glomerular injury in hypercholesterolemia.

Keywords: cortical and medullary renal blood flow; diadenosine tetraphosphate; hypercholesterolemia; kidney; purinergic receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diet, High-Fat / adverse effects
  • Dinucleoside Phosphates / pharmacology*
  • Hemodynamics / drug effects*
  • Hypercholesterolemia / complications*
  • Hypercholesterolemia / metabolism
  • Hypercholesterolemia / physiopathology
  • Kidney / blood supply
  • Kidney / drug effects*
  • Kidney / physiopathology
  • Lipids / blood
  • Male
  • Oxidation-Reduction / drug effects*
  • Purinergic P2 Receptor Agonists / pharmacology*
  • Rats
  • Rats, Wistar
  • Receptors, Purinergic P2 / drug effects
  • Renal Circulation / drug effects

Substances

  • Dinucleoside Phosphates
  • Lipids
  • Purinergic P2 Receptor Agonists
  • Receptors, Purinergic P2
  • diadenosine tetraphosphate